Arterra Bioscience S.p.A. (BIT:ARBS)

Italy · Delayed Price · Currency is EUR

3.110

-0.080 (-2.51%)

Aug 17, 2026, 1:44 PM CET

Arterra Bioscience Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4.7	4.7	4.17	3.34	3.59	4.74
Revenue Growth	20.37%	12.74%	25.08%	-7.10%	-24.27%	13.64%
Gross Profit	2.94	2.94	2.41	1.85	2.44	3.3
Operating Income	1.93	1.93	1.37	1.06	1.6	1.25
Net Income	2.01	2.01	1.34	1.08	1.41	1.11
Earnings Per Share	0.30	0.30	0.20	0.16	-	-
EPS Growth	49.64%	50.09%	24.21%	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025
Italy	2.6	2.6
Abroad	2.05	2.05
Total	4.65	4.65

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1.34	1.34	3.34	3.69	5.99	4.81
Total Debt	0.26	0.26	0.36	0.39	0.49	0.61
Net Cash (Debt)	1.08	1.08	2.99	3.3	5.5	4.2
Net Cash Growth	-63.77%	-63.77%	-9.48%	-40.03%	31.02%	12.69%
Net Cash Per Share	0.16	0.16	0.45	0.50	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1.99	1.99	1.06	1.03	1.4	1.4
Capital Expenditures	-0.45	-0.45	-0.64	-0.07	-0.09	-0.54
Free Cash Flow	1.54	1.54	0.42	0.96	1.3	0.86
Free Cash Flow Growth	156.56%	263.33%	-55.88%	-26.22%	51.99%	521.51%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	62.44%	62.44%	57.85%	55.46%	68.03%	69.69%
Operating Margin	41.06%	41.06%	32.90%	31.75%	44.57%	26.32%
Pretax Margin	42.46%	42.46%	40.77%	39.03%	50.05%	26.86%
Profit Margin	42.64%	42.64%	32.03%	32.26%	39.38%	23.42%
FCF Margin	32.71%	32.71%	10.15%	28.77%	36.23%	18.05%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.130	-	0.130	0.100	0.100	0.050
Dividend Per Share Growth	15.38%	-	30.00%	0%	100.00%	-
Dividend Yield	4.08%	-	7.38%	7.05%	5.66%	2.15%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	10.59	10.02	9.76	10.27	10.17	17.17
P/FCF Ratio	13.80	13.07	30.81	11.52	11.06	22.28
PS Ratio	4.51	4.27	3.13	3.31	4.01	4.02